Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for infants-;during weeks 32–36 of pregnancy.
Applied Behavior Analysis (ABA): Why More Is Not Always Better
Dana D’Ambrosio, M.S., BCBA, LBA, Director, Clinical Development at RethinkFutures In a society where so many want more—more money, more time off, more adventure—few stop to
September 12, 2023